ENTITY

Neurocrine Biosciences (NBIX US)

38
Analysis
Health CareUnited States
Neurocrine Biosciences, Inc. is focused on the discovery and development of therapeutics for neuropsychiatric, neuroinflammatory, and neurodegenerative diseases and disorders. The Company is developing therapeutic interventions for anxiety, depression, Alzheimer's disease, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity, and diabetes.
more
Company Event07 Feb 2025 22:30 • Upcoming
Add To Calendar
Company Event30 Oct 2024 20:00 • Latest
Company Event28 Aug 2024 20:00
Company Event01 Aug 2024 20:00
Company Event01 May 2024 20:00
x